PPB - Services

Complaints, Feedback and Enquiry

Pharmacovigilance January – March 2022 Q3 Report

[featured_image]
  • Version
  • Download 67
  • File Size 439.61 KB
  • File Count 1
  • Create Date May 25, 2022
  • Last Updated June 23, 2022

Pharmacovigilance January - March 2022 Q3 Report

The Pharmacy and Poisons Board is the Drug Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya. The Board regulates the Practice of Pharmacy and the manufacture and trade in drugs and poisons.

PPB has 4 directorates of which the Directorate of Medicines Information and Pharmacovigilance (MIPV) is responsible for Pharmacovigilance, Post-Market Surveillance, Clinical Trials & Medicines Information activities. MIPV shares quarterly pharmacovigilance reports with stakeholders to serve as a feedback mechanism and also encourage all stakeholders to report.

Since the introduction of PV in Kenya, a total of 16,050 individual case safety reports has been submitted to the global data reports 31,369,700(0.06%).

Attached Files

FileAction
PV Summary Reports Q3_2021_2022.pdfDownload

Author

ppb_admin

Leave a comment

Your email address will not be published.